Skip to content

Accepted Student Day Keynote Speakers

Nick Heath, PharmD

Originally from Augusta, Maine, Nick graduated from MCPHS University – Boston campus in 2015 with his Doctor of Pharmacy. Directly after graduation, he started a two-year postdoctoral fellowship within the MCPHS Biopharmaceutical Fellowship Program at Takeda Pharmaceuticals focused in Pharmacovigilance. Nick was the first PharmD fellow at Takeda with the MCPHS University program and served as the MCPHS Fellowship Network President during the program. After the fellowship, Nick began supporting early phase oncology drug development as a Lead Pharmacovigilance Scientist at Takeda. Recently, he has taken on a role to manage the Artificial Intelligence efforts in pharmacovigilance and introduce other digital innovations to the field. Cambridge is one of the world’s hubs for life sciences and finds itself at the junction of academia, healthcare, and innovation. Nick believes there is no better place in the world to see what’s next in the world of medicine. 

Patsy Casalino, PharmD

Originally from Oakville, Connecticut, Patsy attended MCPHS University – Boston campus and graduated this past May with his Doctor of Pharmacy. Since graduation, Patsy has begun his postdoctoral training as a fellow within the MCPHS Biopharmaceutical Fellowship Program at Biogen in Cambridge. Patsy is one of two fellows completing the Regulatory Sciences/Safety and Benefit-Risk Management fellowship. Through the fellowship, Patsy has had the opportunity to contribute to and lead projects across multiple therapeutic areas including Alzheimer’s Diseases, Multiple Sclerosis, and Spinal Muscular Atrophy. When asked, Patsy cites the university’s proximity to the world’s leading biotech hub in Cambridge as one of the most valuable aspects of attending MCPHS University.

John Fanikos

After earning a Bachelor of Science in Pharmacy degree from MCPHS – Boston in 1984, Mr. Fanikos has served in a variety of roles on his journey to Executive Director of Pharmacy at Brigham and Women’s Hospital. John joined BWH as a Research Pharmacist in 1987 and since then has worked extensively in the areas of investigational pharmacy and anticoagulation, where he was instrumental in developing the hospital’s Anticoagulation Management Service. Presently Mr. Fanikos works very closely with BWH Thromboembolism Research Group and has devoted much of his time to writing many articles and textbook chapters. He currently sits on the Board of Directors for the North American Thrombosis Forum, an organization devoted to combating thrombotic disorders through education, research and prevention. John has assumed many administrative roles during his time at Brigham and Women’s. He has worked as an inpatient and outpatient pharmacy supervisor as well as a clinical preceptor in the pharmacy’s Residency Program. John is also the past president of the Massachusetts Society of Health-System Pharmacists and serves as an adjunct Professor of Clinical Pharmacy Practice at MCPHS University. On top of all these contributions to his institution and the field of pharmacy, John has consistently maintained his commitment to the development of students and pharmacists alike. He is never one to shy away from a challenge and continues to be an irreplaceable resource to his staff and an exceptional mentor.

Karen Tubridy

Currently the Senior Vice President and Chief Development Officer at Akebia Therapeutics, Inc. in Cambridge, MA where she oversees Research, Nonclinical, Manufacturing, Quality, and Program Management for the company. Karen has been working in biotechnology for 25+ years at numerous companies in Cambridge, MA with roles increasing in responsibility over time. Prior to joining Akebia, Karen was the Chief Development Officer at Eleven Biotherapeutics. After graduation from MCPHS in 1985 with a B.S. in Pharmacy, Karen worked at Tuft’s Medical Center as a pharmacist. Her experience as a pharmacist helped launch her career in the biotechnology industry which at the time was in its infancy in the Cambridge/Boston area. Karen worked initially in Clinical Research at one of the first biotechnology companies in Cambridge, Genetics Institute, or GI, overseeing clinical trials and moved on to run clinical programs globally. Wyeth Pharmaceuticals acquired GI and Karen was responsible for Global Medical Affairs, Hematology-Oncology at Wyeth. Karen subsequently moved on to other companies taking on responsibility for overall drug development including leading program management and manufacturing. Karen has had the opportunity to work on several novel medicines at Ariad, Syntonix, Biogen, Alexion, and Inspiration Biopharmaceuticals. Eight of these medicines have been approved for use by patients around the world. In addition to her B.S. in Pharmacy Karen received her PharmD from MCPHS University. Karen is also a member of the Board of Trustee’s at MCPHS University.


Why I Chose MCPHS

Alicia Tran, PharmD ’21 and Alessandro Cavaliere, Premed ‘18/PA ’20

Students from our Premed/PA and PharmD programs share why they chose MCPHS.

Read More 

Accepted Freshman Facebook Group

Check out our Accepted ’20 group to connect with future classmates and receive info about important deadlines.

Join the group